V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10315735 | 10056168 | 1.67 | 69 | null | 2017-02-20 | 2017-02-20 | AFATINIB | 02 | null | AFATINIB | 100009113 |
| 10315987 | 10056170 | null | null | Palliative (P) | null | 2020-03-07 | Acalabrutinib | null | N | BUSULFAN | 100912718 |
| 10316080 | 10056171 | 1.68 | 74.7 | Palliative (P) | null | 2019-04-08 | Busulfan Oral | null | null | IPILIMUMAB + NIVOLUMAB | 101101748 |
| 10316128 | 10056172 | 1.58 | 61.1 | Palliative (P) | 2019-07-12 | 2019-10-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DABRAFENIB | 100810380 |
| 10316191 | 10056173 | 1.76 | 76 | 02 | 2014-11-19 | 2021-09-26 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100851709 |
| 10316494 | 10056175 | 1.78 | 58.5 | Neo-adjuvant (N) | 2019-08-15 | 2019-08-16 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101624604 |
| 10316620 | 10056177 | null | null | null | 2016-02-29 | 2016-03-03 | Bortezomib (weekly) | null | null | BORTEZOMIB | 101014406 |
| 10316724 | 10056178 | null | 74 | Palliative (P) | null | 2021-06-01 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 101475330 |
| 10316788 | 10056180 | 1.82 | 101 | null | 2018-10-24 | 2018-11-02 | DABRAFENIB | 02 | null | NIRAPARIB | 100370861 |
| 10316790 | 10056181 | null | null | Palliative (P) | 2021-06-24 | 2021-06-24 | null | null | N | DABRAFENIB | 101806771 |
| 10316928 | 10056182 | 0 | 73.1 | null | 2018-10-08 | 2018-11-23 | CABOZANTINIB | 02 | null | DABRAFENIB | 100487981 |
| 10317030 | 10056184 | 1.66 | 64.1 | Palliative (P) | null | 2020-01-27 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 100690382 |
| 10317170 | 10056188 | 1.52 | 89.3 | Palliative (P) | null | 2021-05-11 | CABOZANTINIB | 02 | N | ACALABRUTINIB | 101516160 |
| 10317183 | 10056189 | 1.61 | 87.5 | null | 2022-02-17 | 2022-02-24 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101831055 |
| 10317188 | 10056190 | null | 67.2 | null | null | 2020-08-17 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101515557 |
| 10317405 | 10056191 | 1.76 | 52.4 | null | 2019-07-11 | 2019-11-13 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100968506 |
| 10317488 | 10056194 | 1.69 | 70.7 | 03 | null | 2019-03-20 | Cisplatin + Radiotherapy | 02 | N | BUSULFAN | 100382314 |
| 10317587 | 10056195 | 1.85 | 76.5 | null | 2020-04-29 | 2020-05-07 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100106289 |
| 10317678 | 10056196 | null | null | Palliative (P) | 2016-10-24 | 2016-10-25 | MELPHALAN | null | N | MELPHALAN | 100739045 |
| 10317699 | 10056197 | 1.72 | 70.8 | null | null | 2019-01-07 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 101176527 |
| 10317826 | 10056198 | null | null | Palliative (P) | 2019-12-20 | 2019-12-27 | AFATINIB | null | N | AFATINIB | 101182847 |
| 10317908 | 10056199 | 1.63 | 71 | Palliative (P) | 2019-07-15 | 2019-07-15 | Palbociclib | 02 | N | PALBOCICLIB | 101360368 |
| 10317936 | 10056200 | null | null | null | null | 2018-12-01 | Methotrexate intrathecal | null | null | METHOTREXATE | 101239262 |
| 10318041 | 10056201 | 1.74 | 87 | null | null | 2022-02-03 | Gemcitabine day 1&8 | 02 | null | GEMCITABINE | 100796850 |
| 10318103 | 10056202 | 1.72 | 92.9 | Adjuvant (A) | 2019-06-13 | 2019-06-28 | Fluorouricil + Folonic Acid (MdG) | 02 | null | BORTEZOMIB + THALIDOMIDE | 101259936 |
| 10318129 | 10056204 | 1.71 | 71 | Palliative (P) | 2022-04-04 | 2022-04-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | ACALABRUTINIB | 100520997 |
| 10318159 | 10056205 | 1.57 | 95.6 | Disease modification (D) | null | 2019-05-19 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100405811 |
| 10318231 | 10056207 | 1.69 | 62.6 | null | 2022-01-29 | 2022-02-19 | Carboplatin + Vinorelbine Oral | null | null | CARBOPLATIN + VINORELBINE | 101338563 |
| 10318278 | 10056208 | null | 124.2 | Neo-adjuvant (N) | 2022-03-11 | 2022-05-29 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100269676 |
| 10318310 | 10056209 | 1.72 | 56.5 | Disease modification (D) | 2018-10-13 | 2018-10-21 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100996145 |
| 10318362 | 10056210 | 1.71 | 83 | null | 2018-02-15 | 2018-02-20 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 101156326 |
| 10318370 | 10056211 | 1.65 | 58 | Neo-adjuvant (N) | 2019-01-10 | 2019-01-19 | AFATINIB | 02 | N | AFATINIB | 100349088 |
| 10318691 | 10056213 | null | 51 | Palliative (P) | null | 2021-07-19 | IPILIMUMAB + NIVOLUMAB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101001809 |
| 10318702 | 10056214 | 1.76 | null | null | 2018-10-21 | 2019-06-24 | Carboplatin + Liposomal Doxorubicin | 02 | null | ACALABRUTINIB | 100428841 |
| 10318744 | 10056215 | 1.72 | 65.6 | Curative (C) | 2020-11-12 | 2020-12-01 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 100917736 |
| 10318813 | 10056216 | 1.75 | 61.8 | null | 2020-07-17 | 2020-07-17 | Palbociclib | 02 | null | PALBOCICLIB | 100441879 |
| 10318898 | 10056217 | 1.6 | 131 | Palliative (P) | 2019-03-12 | 2019-03-13 | Acalabrutinib | N | N | IPILIMUMAB + NIVOLUMAB | 100795384 |
| 10319128 | 10056224 | 1.67 | 68.6 | Palliative (P) | null | 2017-06-19 | Palbociclib | 02 | N | PALBOCICLIB | 100469830 |
| 10319218 | 10056226 | 1.71 | null | null | null | 2021-06-11 | Cyclophosphamide oral | 02 | null | CYCLOPHOSPHAMIDE | 101158355 |
| 10319240 | 10056227 | 1.77 | 91 | Palliative (P) | 2019-01-17 | 2021-03-07 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 101812679 |
| 10319262 | 10056228 | 1.76 | 90.2 | Palliative (P) | 2020-02-10 | 2020-02-10 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101500619 |
| 10319313 | 10056229 | 1.65 | 75.4 | 03 | null | 2021-06-12 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100715766 |
| 10319385 | 10056230 | 1.75 | 67 | Palliative (P) | null | 2018-09-15 | PERTUZUMAB + TRASTUZUMAB | 02 | N | FLUOROURACIL | 100198585 |
| 10319598 | 10056232 | 1.51 | 76 | Palliative (P) | null | 2021-12-15 | Capecitabine (14 day) + Irinotecan | 02 | N | BUSULFAN | 101467129 |
| 10319622 | 10056233 | 1.75 | 54.6 | Palliative (P) | 2019-03-10 | 2019-03-20 | BUSULFAN | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100471829 |
| 10319691 | 10056235 | 1.8 | 120 | null | null | 2019-12-20 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100818205 |
| 10319694 | 10056236 | 1.73 | 64.8 | null | 2019-10-31 | 2020-10-07 | Cabazitaxel | 02 | null | CABAZITAXEL | 100265271 |
| 10319707 | 10056237 | null | null | null | null | 2019-09-16 | Azacitidine | null | null | AZACITIDINE | 101810622 |
| 10320116 | 10056239 | 1.7 | 59.3 | null | 2018-07-03 | 2018-07-25 | CETUXIMAB | 02 | null | CABOZANTINIB | 101535074 |
| 10320173 | 10056240 | 1.7 | 73.8 | Palliative (P) | 2018-09-13 | 2018-10-10 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101159344 |